Liu, Z., Wang, L., Guo, C., Liu, L., Jiao, D., Sun, Z., . . . Han, X. (2021). TTN/OBSCN ‘Double‐Hit’ predicts favourable prognosis, ‘immune‐hot’ subtype and potentially better immunotherapeutic efficacy in colorectal cancer. J Cell Mol Med.

Liu, Zaoqu, Libo Wang, Chunguang Guo, Long Liu, Dechao Jiao, Zhenqiang Sun, Kunpeng Wu, Yanan Zhao, and Xinwei Han. "TTN/OBSCN ‘Double‐Hit’ Predicts Favourable Prognosis, ‘immune‐hot’ Subtype and Potentially Better Immunotherapeutic Efficacy in Colorectal Cancer." J Cell Mol Med 2021.

Liu, Zaoqu, et al. "TTN/OBSCN ‘Double‐Hit’ Predicts Favourable Prognosis, ‘immune‐hot’ Subtype and Potentially Better Immunotherapeutic Efficacy in Colorectal Cancer." J Cell Mol Med 2021.